Print

Eli Lilly and Company (LLY)'s Erbitux Fails In European Colon Cancer Study  
10/11/2010 7:56:58 AM

MILAN, Oct 10 (Reuters) - Two small European studies cast doubt on the benefits of two key bowel cancer drugs on Sunday, puzzling experts at Europe's biggest cancer meeting in Milan.
//-->